Sign in

or Register now

MyOsteoarthritisCentral.com

See all of our health sites at www.HealthCentral.com
Friday, November 21, 2008

Once-a-Year Bone Drug Lowers Fracture Risk

(Page 3)

Patients taking Reclast will also need to take vitamin D and calcium, they added, and some will experience flu-like symptoms which can be alleviated with a nonsteroidal anti-inflammatory drug.

"This appears to be the most potent of the bisphosphonates. It reduced bone turnover more and had a significant effect on fracture rate. The once-a-year dose obviously is attractive," said Dr. Stephen Honig, director of the Osteoporosis Center at the New York University Hospital for Joint Diseases. "This combination makes it potentially a very important drug. The caveat is the potential side effects. Other studies have found atrial fibrillation."

However, unlike one previous trial, the researchers on this study found no differences in reports of the irregular heartbeat known as atrial fibrillation between the two groups. They also found no reports of osteonecrosis of the jaw, a painful jaw condition, which had previously been associated with this class of drugs.

More information

There's more on osteoporosis at the National Osteoporosis Foundation.

  • Page
  • 3
  • >

Ask a Question

Get answers from our experts and community members.

Answer a Question

is my chronic shoulder pain arthritis?

Answer This View all questions >
Free Newsletter
Get weekly updates, news alerts and more on Osteoarthritis and related health conditions.